6505NCM251822: INFLUENZA VIRUS VACCINE.
The INFLUENZA VIRUS VACCINE is a the manufacturer industrial component. Key specifications include immediate_container_type: SYRINGE, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS, part_name_assigned_by_controlling_agency: FLUZONE, TRIVALENT SOUTHERN HEMISPHERE, 2026-2027 FORMULA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-732-0369, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | 10 PRE-FILLED SYRINGES. 0.5 ML EACH: FOR IMMUNIZING PERSONS 6 MONTHS ANDOLDER; PRESERVATIVE FREE; FOR IM ADMINISTRATION; REQUIRES REFRIGERATION BETWEEN 2-8 DEG; DO NOT FREEEZE. |
| immediate_container_type | SYRINGE |
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| part_name_assigned_by_controlling_agency | FLUZONE, TRIVALENT SOUTHERN HEMISPHERE, 2026-2027 FORMULA |
| NSN | 6505-01-732-0369 |
| IMMEDIATE CONTAINER TYPE | SYRINGE |
| SPECIAL FEATURES | 10 PRE-FILLED SYRINGES. 0.5 ML EACH: FOR IMMUNIZING PERSONS 6 MONTHS ANDOLDER; PRESERVATIVE FREE; FOR IM ADMINISTRATION; REQUIRES REFRIGERATION BETWEEN 2-8 DEG; DO NOT FREEEZE. |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FLUZONE, TRIVALENT SOUTHERN HEMISPHERE, 2026-2027 FORMULA |